Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|October 17, 2013
In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infectionC H Chilton, G S Crowther, S D Baines, et al.Journal of Medicinal Chemistry|July 6, 2000
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agentsC Apfel, D W Banner, D Bur, et al.Plos One|December 19, 2015
Human Dermal Fibroblasts Demonstrate Positive Immunostaining for Neuron- and Glia- Specific ProteinsC J Janmaat, K E de Rooij, H Locher, et al.Antimicrobial Agents and Chemotherapy|November 27, 2013
In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infectionsHans H Locher, Peter Seiler, Xinhua Chen, et al.Schmerz (Berlin, Germany)|July 8, 2008
[Risk assessment in pain therapy]D Schoeffel, H R Casser, M Bach, et al.Journal of Medicinal Chemistry|May 16, 2024
Discovery and Structure-Activity Relationship of Cadazolid: A First-In-Class Quinoxolidinone Antibiotic for the Treatment of Clostridioides difficile InfectionGeorg Rueedi, Philippe Panchaud, Astrid Friedli, et al.Journal of Molecular Biology|February 14, 1997
A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistanceG E Dale, C Broger, A D'Arcy, et al.The Journal of Antimicrobial Chemotherapy|October 5, 2015
Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infectionD N Gerding, D W Hecht, T Louie, et al.Journal of Medicinal Chemistry|April 14, 2017
Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative BacteriaJean-Philippe Surivet, Cornelia Zumbrunn, Thierry Bruyère, et al.Journal of Medicinal Chemistry|December 6, 2019
Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous AdministrationPhilippe Panchaud, Jean-Philippe Surivet, Stefan Diethelm, et al.Pageof 5